5311462026-01-012026-03-315311462026-03-315311462025-03-315311462025-04-012026-03-315311462026-01-012026-03-31in-capmkt:OtherExpenses1Member5311462025-04-012026-03-31in-capmkt:OtherExpenses1Member5311462026-03-31OtherNoncurrentAssetsDomain15311462026-03-31OtherCurrentFinancialLiabilitiesDomain15311462026-01-012026-03-31RelatedPartyTransactionDomain15311462025-12-31RelatedPartyTransactionDomain15311462026-03-31RelatedPartyTransactionDomain15311462026-01-012026-03-31RelatedPartyTransactionDomain25311462025-12-31RelatedPartyTransactionDomain25311462026-03-31RelatedPartyTransactionDomain25311462026-01-012026-03-31RelatedPartyTransactionDomain35311462025-12-31RelatedPartyTransactionDomain35311462026-03-31RelatedPartyTransactionDomain35311462026-01-012026-03-31RelatedPartyTransactionDomain45311462025-12-31RelatedPartyTransactionDomain45311462026-03-31RelatedPartyTransactionDomain45311462026-01-012026-03-31RelatedPartyTransactionDomain55311462025-12-31RelatedPartyTransactionDomain55311462026-03-31RelatedPartyTransactionDomain55311462026-01-012026-03-31RelatedPartyTransactionDomain65311462025-12-31RelatedPartyTransactionDomain65311462026-03-31RelatedPartyTransactionDomain65311462026-01-012026-03-31RelatedPartyTransactionDomain75311462025-12-31RelatedPartyTransactionDomain75311462026-03-31RelatedPartyTransactionDomain75311462026-01-012026-03-31RelatedPartyTransactionDomain85311462025-12-31RelatedPartyTransactionDomain85311462026-03-31RelatedPartyTransactionDomain85311462026-01-012026-03-31RelatedPartyTransactionDomain95311462025-12-31RelatedPartyTransactionDomain95311462026-03-31RelatedPartyTransactionDomain95311462026-01-012026-03-31RelatedPartyTransactionDomain105311462025-12-31RelatedPartyTransactionDomain105311462026-03-31RelatedPartyTransactionDomain105311462026-01-012026-03-31AuditorDomain15311462026-03-31Statement15311462026-01-012026-03-31Statement15311462026-03-31StatementDynamic1I1Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares531146MEDICAMEQNOTLISTEDINE646B01010MEDICAMEN BIOTECH LIMITEDMain BoardEquity2025-04-012026-03-312026-05-272026-05-20INRLakhsQuarterlyFourth quarterSingle segmentPHARMACEUTICALS2026-05-2701:00:002026-05-2702:00:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2026-04-01www.medicamen.comtrue1true2026-01-012026-03-31AuditedStandalone5468080001726300056407100025431200006104100062403000598900017250000127781000528776000352950000352950006527000-9540005573000029722000000029722000029722000135628000102.192.19002.192.192025-04-012026-03-31AuditedStandalone178845800031043000181950100091813800007423800022786700027845000705870003853480001704023000115478000011547800025482000-4091000213910000940870000000940870000940870001356280001006.946.94006.946.94Other Expenses127781000Other Expenses38534800083265300005716000806140004957600013019000032137000553305000155400100070079500006490520003108400002663100037386400013603870002061182000361518300013562800026616610002797289000279728900077710000007771000236620003143300036155300010205000366064000376269000163520007541740006805000254820007864610008178940003615183000Other non-current assets553305000Other current financial liabilities1635200027845000-79422000-628590000-93016000-140775000-3713000042550000-35294000078600000705870000-327820000000000000000-370731000-25525300000-17302000200000000-29255500000000000-4583000000000000000000000001730200000-2852800000848200052719700000009713800000135630002784500004710000596119000275036000027503600035803000310839000Medicamen Biotech Limited******Shivalik Rasayan Limited******Holding CompanySale of goods or services100000000Approved29400000Medicamen Biotech Limited******Shivalik Rasayan Limited******Holding CompanyPurchase of goods or services100000000Approved10413500000Medicamen Biotech Limited******Kanchan Sharma******Related person to the DirectorAny other transactionRent Paid10000000Approved31500000Medicamen Biotech Limited******Chem Pharma Pvt Ltd******Entities with joint control or significant influence over entityAny other transactionProfessional Services20000000Approved129600000Medicamen Biotech Limited******Medicamen Life Sciences Private Limited******Subsidiary CompanySale of goods or services50000000Approved789500000Medicamen Biotech Limited******Rajesh Madan******KMP (CEO)Remuneration20000000Approved293800000Medicamen Biotech Limited******Parul Chaudhary******KMP (CS)Remuneration20000000Approved68900000Medicamen Biotech Limited******Chandan Kumar******KMP (CFO)Remuneration20000000Approved44800000Medicamen Biotech Limited******Medicamen Life Sciences Private Limited******Subsidiary CompanyAny other transactionReceivable50000000Approved0015084000Medicamen Biotech Limited******Ashwani Kumar Sharma******Whole Time DirectorRemuneration20000000Approved338400000121394000AuditedtrueM/s Rai Qimat & Associatestrue2026-11-303550390000000Preferential Issues2025-04-245356810002026-03-31falsefalseNANANAParul ChoudharyCompany Secretary and Compliance OfficerNew Delhi2026-05-27a) Drug Development of 50 SKUs for Regulated markets b) Registration of dossiers, etc. c) Meet the Enhanced working capital requirements d) Capital expenditure in some area of upgradation of the existing facilities e) Expansion of operations in Domestic Market f) General Corporate PurposesNA53568100002929820000